Crescent Innovations Inc. announced today the sale of its technology related to skin regeneration, plus various intellectual property and know-how assets.
WESTFORD, Mass., May 14, 2024 /PRNewswire-PRWeb/ -- Crescent Innovations Inc. announced today the sale of its technology related to skin regeneration, plus various intellectual property and know-how assets. Chris Finn, President of the advisory firm Alternotio announced today that Crescent Innovations has retained Alternotio to sell the assets using a sealed bid sales process on June 28, 2024.
The global wound care market size was estimated at USD 22.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.17% from 2024 to 2030. The demand for wound care products is increasing owing to the increasing number of surgical cases and the rising prevalence of chronic diseases across the globe. Furthermore, the increasing incidence of diabetes due to a sedentary lifestyle is one of the leading factors contributing to market growth. For instance, as per a report by Centers for Disease Control and Prevention (CDC), which was last reviewed in April 2023, 37.3 million Americans have diabetes. Similarly, as per the same source, 96 million American adults have prediabetes.
Crescent Innovations has developed a new trade secret protected method for autologous keratinocyte wound care. This is enabled by Crescent Innovations' patent US7371399B2. The technology allows for a simple day procedure to harvest keratinocytes, embed them in a delivery matrix, and deliver them to the wound site. This technology showed superior performance to all standard practices in an in vitro model for wound healing.
The assets will be sold at a sealed bid sale on June 28, 2024, at noon. Parties interested in purchasing any or all of the assets must sign a confidentiality agreement, which can be obtained by contacting Chris Finn at [email protected] or calling +1 (978) 882 - 2586. Negotiated offers are welcome, but any negotiated sale must be concluded prior to opening bids on the date specified above and must conform to the terms set forth for sealed bids.
About Crescent Innovations Inc.
Crescent Innovations Inc. is a firm focused on the development of biological polymers to create non surgical regenerative solutions for chronic conditions. The firm currently is focused on innovating technology to solve TMJ disorders and singular maladies. If interested in TMJ disorders, please contact Crescent Innovations directly at www.crescentinnovations.com
About Alternotio.
Alternotio is an advisory firm, that specializes in the sale of non-lead and distressed intellectual property. Alternotio occasionally works with unique tangible assets that have a substantial intellectual property component.
Media Contact
Al Prescott, Crescent Innovations, INC., 1 978.764.8604, [email protected], www.crescentinnovations.com
SOURCE Crescent Innovations, INC.
Share this article